These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15368968)

  • 1. [Positron emission tomography: a clinical and biological research tool].
    Kotzki PO
    J Soc Biol; 2004; 198(2):163-8. PubMed ID: 15368968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Positron emission tomography: basic principle and radionuclides/probes for metabolic/functional analysis].
    Saga T; Yoshikawa K; Ishizu K
    Rinsho Byori; 2007 Jul; 55(7):630-8. PubMed ID: 17718059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-animal PET: a promising, non-invasive tool in pre-clinical research.
    Schnöckel U; Hermann S; Stegger L; Law M; Kuhlmann M; Schober O; Schäfers K; Schäfers M
    Eur J Pharm Biopharm; 2010 Jan; 74(1):50-4. PubMed ID: 19482080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small animal positron emission tomography in food sciences.
    Bergmann R; Pietzsch J
    Amino Acids; 2005 Dec; 29(4):355-76. PubMed ID: 16142524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET and PET/CT in pediatric oncology.
    Jadvar H; Connolly LP; Fahey FH; Shulkin BL
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of positron emission tomography in sarcomas.
    Schuetze SM
    Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiopharmaceuticals: molecular imaging using positron emission tomography.
    Antoni G; Långström B
    Handb Exp Pharmacol; 2008; (185 Pt 1):177-201. PubMed ID: 18626804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic monitoring of chemosensitivity with 18FDG PET.
    Jerusalem G; Belhocine TZ
    Methods Mol Med; 2005; 111():417-40. PubMed ID: 15911993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial and subsequent approach for the synthesis of 18FDG.
    Fowler JS; Ido T
    Semin Nucl Med; 2002 Jan; 32(1):6-12. PubMed ID: 11839070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Positron emission tomography in oncology: an update].
    Jerusalem G; Withofs N; Rorive A; Hustinx R
    Rev Prat; 2007 Nov; 57(17):1864-70. PubMed ID: 18095621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles and clinical applications of positron emission tomography.
    Gardner SF; Green JA; Bednarczyk EM; Farnett L; Miraldi F
    Am J Hosp Pharm; 1992 Jun; 49(6):1499-506. PubMed ID: 1530002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of FDG PET.
    Hoh CK
    Nucl Med Biol; 2007 Oct; 34(7):737-42. PubMed ID: 17921026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular PET/CT imaging-guided radiation therapy treatment planning.
    Zaidi H; Vees H; Wissmeyer M
    Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.
    Miller PW; Long NJ; Vilar R; Gee AD
    Angew Chem Int Ed Engl; 2008; 47(47):8998-9033. PubMed ID: 18988199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
    Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
    IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.